Area of research
Cellular and Molecular Neuroscience · Molecular Biology
Research interest
Research interests include Neuropeptides and Animal Physiology, Receptor Mechanisms and Signaling, Migraine and Headache Studies, and Neuroendocrine regulation and behavior.
Response to Letter to the Editor regarding "Calcitonin gene-related peptide and headache: Comparison of two commonly used assay kits highlights the perils of measuring neuropeptides with enzyme-linked immunosorbent assays".
The Concise Guide to PHARMACOLOGY 2025/26: G protein-coupled receptors.
Calcitonin gene-related peptide and headache: Comparison of two commonly used assay kits highlights the perils of measuring neuropeptides with enzyme-linked immunosorbent assays.
Be CLEAR to ensure methodological and data transparency
Development and pharmacological characterization of novel multi- calcitonin gene-related peptide and pituitary adenylate cyclase-activating peptide receptor antagonists.
Be CLEAR to ensure methodological and data transparency
Decoding PACAP signaling: Splice variants, pathways and designer drugs.
Pharmacological characterization of ubrogepant and atogepant in cAMP assays at human, rat, and mouse calcitonin family receptors in transfected cells.
Calcitonin receptors in GtoPdb v.2025.3
Pituitary adenylate cyclase-activating polypeptide signalling as a therapeutic target in migraine
Pituitary adenylate cyclase-activating polypeptide signalling as a therapeutic target in migraine.
Serum calcitonin gene-related peptide in patients with persistent post-concussion symptoms, including headache: a cohort study.
Pharmacology of PACAP and VIP receptors in the spinal cord highlights the importance of the PAC<sub>1</sub> receptor.
Pharmacological characterisation of erenumab, Aimovig, at two calcitonin gene-related peptide responsive receptors.
Converting the Amyloidogenic Islet Amyloid Polypeptide into a Potent Nonaggregating Peptide Ligand by Side Chain-to-Side Chain Macrocyclization.
Pharmacotherapies for Migraine and Translating Evidence From Bench to Bedside.
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors.
CGRP physiology, pharmacology, and therapeutic targets: migraine and beyond.
Elucidating the Interactome of G Protein-Coupled Receptors and Receptor Activity-Modifying Proteins.
Calcitonin receptors in GtoPdb v.2023.1
Comment on Yoo et al. Amylin Protein Expression in the Rat Brain and Neuro-2a Cells. <i>Int. J. Mol. Sci.</i> 2022, <i>23</i>, 4348.
A structural basis for amylin receptor phenotype.
Beyond CGRP: The calcitonin peptide family as targets for migraine and pain.
Elucidating the Interactome of G Protein-Coupled Receptors and Receptor Activity-Modifying Proteins
CGRP receptor antagonists for migraine. Are they also AMY<sub>1</sub> receptor antagonists?
Characterisation of agonist signalling profiles and agonist-dependent antagonism at PACAP-responsive receptors: Implications for drug discovery.
Pharmacological characterisation of mouse calcitonin and calcitonin receptor-like receptors reveals differences compared with human receptors.
A narrative review of the calcitonin peptide family and associated receptors as migraine targets: Calcitonin gene-related peptide and beyond.
Calcitonin receptor antibody validation and expression in the rodent brain.